OBSOLETE: Congenital hydronephrosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2190
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital hydronephrosis refers to the dilation of the renal pelvis and calyces of the kidney that is present at birth, resulting from obstruction or impaired drainage of urine from the kidney. This condition is now considered an obsolete entry in Orphanet (ORPHA:2190), as it has been reclassified and incorporated into more specific diagnostic categories such as congenital ureteropelvic junction obstruction, congenital megaureter, or other obstructive uropathies. The condition primarily affects the urinary system, with the kidneys being the main organ involved. When urine cannot drain properly, it accumulates in the kidney, causing swelling that can range from mild to severe. If left untreated, significant hydronephrosis can lead to progressive kidney damage and loss of renal function. Congenital hydronephrosis is frequently detected prenatally during routine ultrasound examinations, making it one of the most commonly identified fetal anomalies. Key symptoms may include flank pain, urinary tract infections, and in severe cases, palpable abdominal mass in newborns. Many mild cases resolve spontaneously without intervention. Treatment depends on the underlying cause and severity, ranging from watchful waiting with serial ultrasound monitoring to surgical intervention such as pyeloplasty (repair of the ureteropelvic junction) in cases with significant obstruction or declining kidney function. Early detection and appropriate management are essential to preserve renal function. Patients are advised to consult current disease classifications for the most specific and up-to-date diagnostic terminology.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Congenital hydronephrosis.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Congenital hydronephrosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Congenital hydronephrosis community →

No specialists are currently listed for OBSOLETE: Congenital hydronephrosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Congenital hydronephrosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Congenital hydronephrosisForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Congenital hydronephrosis.

Start the conversation →

Latest news about OBSOLETE: Congenital hydronephrosis

No recent news articles for OBSOLETE: Congenital hydronephrosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Congenital hydronephrosis

What is OBSOLETE: Congenital hydronephrosis?

Congenital hydronephrosis refers to the dilation of the renal pelvis and calyces of the kidney that is present at birth, resulting from obstruction or impaired drainage of urine from the kidney. This condition is now considered an obsolete entry in Orphanet (ORPHA:2190), as it has been reclassified and incorporated into more specific diagnostic categories such as congenital ureteropelvic junction obstruction, congenital megaureter, or other obstructive uropathies. The condition primarily affects the urinary system, with the kidneys being the main organ involved. When urine cannot drain properl

At what age does OBSOLETE: Congenital hydronephrosis typically begin?

Typical onset of OBSOLETE: Congenital hydronephrosis is neonatal. Age of onset can vary across affected individuals.